Dr. Waqaas will address, meet with, world leaders and medical innovators on pressing challenges and solutions in global cardiovascular health, digital health and AIREDWOOD CITY, CA / ACCESSWIRE / May 10
CRANFORD, N.J., May 8, 2023 /PRNewswire/ Citius Pharmaceuticals Inc. , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care. | May 8, 2023
/PRNewswire/ Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and.
CRANFORD, N.J., April 24, 2023 /PRNewswire/ Citius Pharmaceuticals, Inc. , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical. | April 24, 2023
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, today reported that